Sixty percent of all healthcare payments are in some form of value-based care, says Dave Snow, CEO of Cedar Gate Technologies.
The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.
Investments in workforce, integrated technologies will broaden and strengthen care in rural areas, says Anna Basevich, SVP at Arcadia.
The Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI, says Dr. Baligh Yehia, president of Jefferson Health.
